2276. Immunogenicity of Takeda’s Bivalent Virus-Like Particle (VLP) Norovirus Vaccine (NoV) Candidate in Children From 6 Months up to 4 Years of Age

por Masuda, Taisei, Lefevre, Inge, Mendelman, Paul, Sherwood, Jim, Bizjajeva, Svetlana, Borkowski, Astrid
Publicado 2018

Bivalent Norovirus VLP Vaccine Candidate in Older Adults: Impact of MPL and a Second Dose in a Randomized, Controlled, Double-Blind Clinical Trial

por Sherwood, Jim, Cramer, Jakob, Cam, Nancy Bouveret Le, Lin, Stella, Baehner, Frank, Mendelman, Paul, Borkowski, Astrid
Publicado 2017

Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: A randomized, observer-blind, controlled ph...

por Cramer, Jakob P., Jimeno, José, Han, Htay Htay, Lin, Stella, Hartmann, Katharina, Borkowski, Astrid, Sáez-Llorens, Xavier
Publicado 2020

Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study

por Sirivichayakul, Chukiat, Barranco-Santana, Elizabeth A, Rivera, Inés Esquilín, Kilbury, Jennifer, Raanan, Marsha, Borkowski, Astrid, Papadimitriou, Athanasia, Wallace, Derek
Publicado 2020

Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, contro...

por Tricou, Vianney, Essink, Brandon, Ervin, John E., Turner, Mark, Escudero, Ian, Rauscher, Martina, Brose, Manja, Lefevre, Inge, Borkowski, Astrid, Wallace, Derek
Publicado 2023

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind tri...

por López, Pio, López-Medina, Eduardo, Sáez-Llorens, Xavier, deAntonio, Rodrigo, Masuda, Taisei, Mendelman, Paul M., Sherwood, James, Baehner, Frank, Borkowski, Astrid
Publicado 2023

Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial

por Leroux-Roels, Geert, Cramer, Jakob P, Mendelman, Paul M, Sherwood, James, Clemens, Ralf, Aerssens, Annelies, De Coster, Ilse, Borkowski, Astrid, Baehner, Frank, Van Damme, Pierre
Publicado 2018

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial

por Turner, Mark, Papadimitriou, Athanasia, Winkle, Peter, Segall, Nathan, Levin, Michael, Doust, Matthew, Johnson, Casey, Lucksinger, Gregg, Fierro, Carlos, Pickrell, Paul, Raanan, Marsha, Tricou, Vianney, Borkowski, Astrid, Wallace, Derek
Publicado 2020

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine

por Ramani, Sasirekha, Neill, Frederick H., Ferreira, Jennifer, Treanor, John J., Frey, Sharon E., Topham, David J., Goodwin, Robert R., Borkowski, Astrid, Baehner, Frank, Mendelman, Paul M., Estes, Mary K., Atmar, Robert L.
Publicado 2017

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City

por Biswal, Shibadas, Mendez Galvan, Jorge Fernando, Macias Parra, Mercedes, Galan-Herrera, Juan-Francisco, Carrascal Rodriguez, Monica Belisa, Rodriguez Bueno, Esteban Patricio, Brose, Manja, Rauscher, Martina, LeFevre, Inge, Wallace, Derek, Borkowski, Astrid
Publicado 2021

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

por Rivera, Luis, Biswal, Shibadas, Sáez-Llorens, Xavier, Reynales, Humberto, López-Medina, Eduardo, Borja-Tabora, Charissa, Bravo, Lulu, Sirivichayakul, Chukiat, Kosalaraksa, Pope, Martinez Vargas, Luis, Yu, Delia, Watanaveeradej, Veerachai, Espinoza, Felix, Dietze, Reynaldo, Fernando, LakKumar, Wickramasinghe, Pujitha, Duarte MoreiraJr, Edson, Fernando, Asvini D, Gunasekera, Dulanie, Luz, Kleber, Venâncioda Cunha, Rivaldo, Rauscher, Martina, Zent, Olaf, Liu, Mengya, Hoffman, Elaine, LeFevre, Inge, Tricou, Vianney, Wallace, Derek, Alera, MariaTheresa, Borkowski, Astrid
Publicado 2021

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

por López-Medina, Eduardo, Biswal, Shibadas, Saez-Llorens, Xavier, Borja-Tabora, Charissa, Bravo, Lulu, Sirivichayakul, Chukiat, Vargas, Luis Martinez, Alera, Maria Theresa, Velásquez, Hector, Reynales, Humberto, Rivera, Luis, Watanaveeradej, Veerachai, Rodriguez-Arenales, Edith Johana, Yu, Delia, Espinoza, Felix, Dietze, Reynaldo, Fernando, Lak Kumar, Wickramasinghe, Pujitha, Duarte Moreira, Edson, Fernando, Asvini D, Gunasekera, Dulanie, Luz, Kleber, da Cunha, Rivaldo Venâncio, Tricou, Vianney, Rauscher, Martina, Liu, Mengya, LeFevre, Inge, Wallace, Derek, Kosalaraksa, Pope, Borkowski, Astrid
Publicado 2020